Visualitza per autoria "Torrens, Marta"

Ordena per: Ordre: Resultats:

  • A biomarker to differentiate between primary and cocaine-induced major depression in cocaine use disorder: the role of platelet IRAS/Nischarin (I1-Imidazoline Receptor)
    Keller, Benjamin; Mestre-Pintó, Juan Ignacio; Álvaro-Bartolomé, María; Martínez-Sanvisens, Diana; Farré Albaladejo, Magí; García-Fuster, M. Julia; García Sevilla, Jesús; Torrens, Marta; The NEURODEP Group (Frontiers, 2017)
    The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced ...
  • A comparison of acute pharmacological effects of methylone and MDMA administration in humans and oral fluid concentrations as biomarkers of exposure
    Poyatos, Lourdes; Papaseit Fontanet, Esther; Olesti Muñoz, Eulàlia, 1991-; Pérez Mañá, Clara; Ventura, Mireia; Carbón Mallol, Xoán; Grifell Guardia, Marc; Fonseca Casals, Francina, 1972-; Torrens, Marta; Torre Fornell, Rafael de la; Farré Albaladejo, Magí (MDPI, 2021)
    Considered the β-keto analogue of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), 3,4-Methylenedioxymethcathinone (methylone) is a synthetic cathinone. Over the years, methylone has been used as a substitute for ...
  • A feasibility study of patients with major depression and substance use disorders: vortioxetine as maintenance treatment
    Basurte-Villamor, Ignacio; Vega, Pablo; Roncero, Carlos; Martínez Raga, Jose; Grau-López, Lara; Aguilar, Lourdes; Torrens, Marta; Szerman, Nestor (Dove Medical Press, 2022)
    Background: limited studies have evaluated the effectiveness of vortioxetine in real-world settings, and none of them has involved patients with dual depression (major depressive disorder [MDD] and substance use disorder ...
  • A gender perspective of addictive disorders
    Fonseca Casals, Francina, 1972-; Robles-Martínez, María; Tirado Muñoz, Judit; Alías i Ferri, María; Mestre-Pintó, Juan Ignacio; Coratu, Ana Maria; Torrens, Marta (Springer, 2021)
    Purpose of review: Substance use disorders (SUD) affect differentially women and men. Although the prevalence has been reported higher in men, those women with addictive disorders present a more vulnerable profile and are ...
  • A multicenter phase II rater-blinded randomized controlled trial to compare the effectiveness of eye movement desensitization reprocessing therapy vs. treatment as usual in patients with substance use disorder and history of psychological trauma: a study design and protocol
    Valiente Gómez, Alicia; Moreno Alcázar, Ana; Radua, Joaquim; Hogg, Bridget; Blanco Hinojo, Laura, 1981-; Lupo, Walter; Pérez Solá, Victor; Robles-Martínez, María; Torrens, Marta; Amann, Benedikt Lorenz (Frontiers, 2019)
    Background: Psychological trauma has a strong negative impact on the onset, course and prognosis of substance use disorders (SUD). Few trauma-oriented treatment approaches have been trialed, but preliminary evidence exists ...
  • A systematic review of digital interventions for smoking cessation in patients with serious mental illness
    Martínez Agulleiro, Luis; Patil, Bhagyashree; Firth, Joseph; Sawyer, Chelsea; Amann, Benedikt Lorenz; Fonseca Casals, Francina, 1972-; Torrens, Marta; Pérez Solá, Victor; Castellanos, Francisco X.; Kane, John M.; Guinart, Dani (Cambridge University Press, 2023)
    Tobacco smoking is highly prevalent among patients with serious mental illness (SMI), with known deleterious consequences. Smoking cessation is therefore a prioritary public health challenge in SMI. In recent years, several ...
  • Abuse potential of cathinones in humans: a systematic review
    Poyatos, Lourdes; Torres, Adrián; Papaseit Fontanet, Esther; Pérez Mañá, Clara; Hladun, Olga; Núñez-Montero, Melani; de la Rosa, Georgina; Torrens, Marta; Fuster, Daniel; Muga, Roberto; Farré Albaladejo, Magí (MDPI, 2022)
    Introduction and objective: assessing the abuse potential of new substances with central nervous system activity is essential for preventing possible risks of misuse and addiction. The same methodology is recommended for ...
  • Acute effects of 2C-E in humans: an observational study
    Papaseit Fontanet, Esther; Olesti Muñoz, Eulàlia, 1991-; Pérez Mañá, Clara; Torrens, Marta; Grifell Guardia, Marc; Ventura, Mireia; Pozo Mendoza, Óscar J., 1975-; de Sousa Fernandes Perna, Elizabeth B.; Ramaekers, Johannes G.; Torre Fornell, Rafael de la; Farré Albaladejo, Magí (Frontiers, 2020)
    2,5-Dimethoxy-4-ethylphenethylamine (2C-E) is psychedelic phenylethylamine, with a chemical structure similar to mescaline, used as new psychoactive substance (NPS). It inhibits norepinephrine and serotonin uptake and, ...
  • Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.
    González, Débora; Torrens, Marta; Farré Albaladejo, Magí (Hindawi Publishing Corporation, 2015)
    BACKGROUND: 2C-B (Nexus) is one of the most widespread novel psychoactive substances. There is limited information about its pharmacological properties, and few studies in humans concern its acute and chronic effects. 2C-B ...
  • Acute pharmacological effects of 2C-B in humans: An observational study
    Papaseit Fontanet, Esther; Farré Albaladejo, Magí; Pérez Mañá, Clara; Torrens, Marta; Ventura, Mireia; Pujadas, Mitona; Torre Fornell, Rafael de la; González, Débora (Frontiers, 2018)
    2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT2A), 5-hydroxytryptamine-2B (5-HT2B), and ...
  • Acute pharmacological effects of oral and intranasal mephedrone: an observational study in humans
    Papaseit Fontanet, Esther; Olesti Muñoz, Eulàlia, 1991-; Pérez Mañá, Clara; Torrens, Marta; Fonseca Casals, Francina, 1972-; Grifell Guardia, Marc; Ventura, Mireia; Torre Fornell, Rafael de la; Farré Albaladejo, Magí (MDPI, 2021)
    Mephedrone (4-methylmethcathinone) is a synthetic cathinone with psychostimulant properties which remains one of the most popular new psychoactive substances (NPS). It is frequently used orally and/or intranasally. To date, ...
  • Addictive and other mental disorders: a call for a standardized definition of dual disorders
    Szerman, Nestor; Torrens, Marta; Maldonado, Rafael, 1961-; Balhara, Yatan Pal Singh; Salom, Caroline; Maremmani, Icro; Sher, Leo; Didia-Attas, Javier; Chen, Jun; Baler, Ruben; World Association on Dual Disorders (WADD) (Nature Research, 2022)
    The persistent difficulty in conceptualizing the relationship between addictive and other mental disorders stands out among the many challenges faced by the field of Psychiatry. The different philosophies and schools of ...
  • Alcohol induced depression: clinical, biological and genetic features
    Farré Martínez, Adriana; Tirado Muñoz, Judit; Spataro, Nino; Alías i Ferri, María; Torrens, Marta; Fonseca Casals, Francina, 1972- (MDPI, 2020)
    Background: In clinical practice, there is the need to have clinical and biological markers to identify induced depression. The objective was to investigate clinical, biological and genetic differences between Primary Major ...
  • Antidepressant drugs and COVID-19: A review of basic and clinical evidence
    Mas, Marta; García-Vicente, Juan Antonio; Estrada-Gelonch, Anaïs; Pérez Mañá, Clara; Papaseit Fontanet, Esther; Torrens, Marta; Farré Albaladejo, Magí (MDPI, 2022)
    The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that ...
  • Assessment of efficacy and tolerability of medicinal cannabinoids in patients with multiple sclerosis: a systematic review and meta-analysis
    Torres-Moreno, Mari Carmen; Papaseit Fontanet, Esther; Torrens, Marta; Farré Albaladejo, Magí (American Medical Association, 2018)
    IMPORTANCE: Cannabinoids have antispastic and analgesic effects; however, their role in the treatment of multiple sclerosis (MS) symptoms is not well defined. OBJECTIVE: To conduct a systematic review and meta-analysis to ...
  • Attenuated frontal and sensory inputs to the basal ganglia in cannabis users
    Blanco Hinojo, Laura, 1981-; Pujol, Jesús; Harrison, Ben J.; Macià, Dídac; Batalla, Albert; Nogué, Santiago; Torrens, Marta; Farré, Magí; Deus, Joan; Martín Santos, Rocío (Wiley, 2017)
    Heavy cannabis use is associated with reduced motivation. The basal ganglia, central in the motivation system, have the brain's highest cannabinoid receptor density. The frontal lobe is functionally coupled to the basal ...
  • BDNF and cortisol in the diagnosis of cocaine-induced depression
    Fonseca Casals, Francina, 1972-; Mestre-Pintó, Juan Ignacio; Rodríguez-Minguela, Rocío; Papaseit Fontanet, Esther; Pérez Mañá, Clara; Langohr, Klaus; Barbuti, Margherita; Farré Albaladejo, Magí; Torrens, Marta; Neurodep Group (Frontiers, 2022)
    Background: Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high ...
  • Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment
    Torrens, Marta; Soyemi, Tokunbo; Bowman, Darcy; Schatz, Eberhard (BioMed Central, 2020)
    Background: Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured. However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim ...
  • Cannabinoids: from pot to lab
    Papaseit Fontanet, Esther; Pérez Mañá, Clara; Pérez-Acevedo, Ana Pilar; Hladun, Olga; Torres-Moreno, Mari Carmen; Muga, Roberto; Torrens, Marta; Farré Albaladejo, Magí (Ivyspring International Publisher, 2018)
    Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical ...
  • CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial
    Mestre-Pintó, Juan Ignacio; Fonseca Casals, Francina, 1972-; Schaub, M. P.; Baumgartner, Christian F.; Alías i Ferri, María; Torrens, Marta (BioMed Central, 2022)
    Background: cannabis is the most-frequently used illicit drug in Europe. Over the last few years in Spain, treatment demand has increased, yet most cannabis users do not seek treatment despite the related problems. A ...

Cerca

Visualitza

El meu compte

Amb col·laboració de Complim Participem